Mark Lupher

Biography

 Dr. Mark Lupher joins Sutro with over twenty years of biomedical research and development experience from discovery through translational clinical development with both biologics and small molecules.  He has been an active consultant for Sutro’s preclinical and translational initiatives for over one year. In his earlier position as chief scientific officer of Promedior, Dr. Lupher oversaw several IND applications and early clinical development programs for phase I and phase II clinical trials, as well as Promedior’s drug discovery, preclinical development and intellectual property portfolio.  Previously, at ICOS Corporation and Immunex Corporation, he led various drug discovery programs. Dr. Lupher received his Ph.D. in Immunology from Harvard University in Cambridge, MA.

Research Interest

phase I and phase II clinical trials, translational clinical development with both biologics and small molecules